$169.98
-0.89-0.52%
Last update: Nov 11, 9:53 AM
Gilead Sciences Inc (GILD) Stock Price, Quote, News & History
GILDNASDAQ
Democrats have two ways to pressure drugmakers. Eli Lilly, Gilead, Merck, Bristol Myers face different levels of Medicare pricing exposure.
You can purchase shares of Gilead Sciences (NASDAQ:GILD) through any online brokerage.
Other companies in Gilead Sciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Vertex Pharmaceuticals Inc (NASDAQ:VRTX), Moderna Inc (NASDAQ:MRNA) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Gilead Sciences has a consensus price target of $150.79.
The stock price for Gilead Sciences (NASDAQ: GILD) is $169.98 last updated November 11, 2026 at 9:53 AM EST.
There are no upcoming dividends for Gilead Sciences.
Gilead Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for Gilead Sciences.
Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug...
